Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality

ConclusionsTemperature conditions for THERAFLEX MB‐Plasma treatment must be carefully controlled to assure uniform quality of pathogen‐reduced plasma in routine production. Inactivation of cooled plasma is not recommended.

Source: Vox Sanguinis - February 1, 2018 Category: Hematology Authors: U. Gravemann, W. Handke, C. Sumian, I. Alvarez, S. Reichenberg, T. H. M üller, A. Seltsam Tags: Original Paper Source Type: research